World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
73
Citations
19336
World Ranking
2136
National Ranking
1039

Ruth A. Karron publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ruth A. Karron sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 208 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ruth A. Karron D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ruth A. Karron sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 73 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ruth A. Karron is affiliated with Johns Hopkins University in the United States and has contributed extensively to the field of medicine, with a particular focus on epidemiology, obstetrics and gynecology, health, infectious diseases, and pediatrics, perinatology, and child health. Their research primarily addresses issues related to respiratory viral infections, vaccine coverage and hesitancy, and global maternal and child health.

Their work features prominently in several publication venues. The most frequent include Vaccine, bioRxiv (Cold Spring Harbor Laboratory), Open Forum Infectious Diseases, The Journal of Infectious Diseases, and Human Vaccines & Immunotherapeutics.

Some of Ruth A. Karron's recent papers encompass a range of public health and vaccine-related topics, including:

  • Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications, 2022, Vaccine
  • The need for inclusion of pregnant women in COVID-19 vaccine trials, 2021, Vaccine
  • Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting, 2020, Vaccine
  • Live-attenuated Vaccines Prevent Respiratory Syncytial Virus-associated Illness in Young Children, 2020, American Journal of Respiratory and Critical Care Medicine
  • Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review, 2021, Vaccine

The scientist collaborates frequently with a group of coauthors, including Rupali J. Limaye, Berhaun Fesshaye, Prachi Singh, Eleonor Zavala, and Maria Deloria Knoll. These collaborations often align with their research focus on vaccine effectiveness, infectious diseases, and public health interventions.

Their contributions span several main topics, notably:

  • COVID-19 Impact on Reproduction
  • Respiratory viral infections research
  • Vaccine Coverage and Hesitancy
  • Pneumonia and Respiratory Infections
  • Global Maternal and Child Health
  • Viral gastroenteritis research and epidemiology
  • SARS-CoV-2 and COVID-19 Research

Best Publications

  • Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2020-21 Influenza Season.

    Lisa A. Grohskopf;Leslie Z. Sokolow;Leslie Z. Sokolow;Sonja J. Olsen;Joseph S. Bresee

  • Causes of severe pneumonia requiring hospital admission in children without HIV infection from Africa and Asia: the PERCH multi-country case-control study

    Katherine L. O'Brien;Henry C. Baggett;W. Abdullah Brooks;Daniel R. Feikin

  • Safety and Immunogenicity Trial in Adult Volunteers of a Human Papillomavirus 16 L1 Virus-Like Particle Vaccine

    Clayton D. Harro;Yuk Ying Susana Pang;Richard B.S. Roden;Allan Hildesheim

  • Prevention and Control of Seasonal Influenza with Vaccines.

    Lisa A. Grohskopf;Leslie Z. Sokolow;Karen R. Broder;Sonja J. Olsen

  • Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

    Ruth A. Karron;Deborah A. Buonagurio;Alice F. Georgiu;Stephen S. Whitehead

  • A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease

    Fernando P. Polack;Michael N. Teng;Peter L. Collins;Gregory A. Prince

  • The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates.

    Natalie I Mazur;Deborah Higgins;Marta C Nunes;José A Melero

  • Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3'-untranslated region.

    Anna P. Durbin;Ruth A. Karron;Wellington Sun;David W. Vaughn

  • Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy

    Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Juliette Thompson

  • Identification of a Recombinant Live Attenuated Respiratory Syncytial Virus Vaccine Candidate That Is Highly Attenuated in Infants

    Ruth A. Karron;Peter F. Wright;Robert B. Belshe;Bhagvanji Thumar

  • Evaluation of Two Live, Cold-Passaged, Temperature-Sensitive Respiratory Syncytial Virus Vaccines in Chimpanzees and in Human Adults, Infants, and Children

    Ruth A. Karron;Peter F. Wright;James E. Crowe;Mary Lou Clements‐Mann

  • Respiratory Syncytial Virus Vaccines

    Robert A. Dudas;Ruth A. Karron

  • The Definition of Pneumonia, the Assessment of Severity, and Clinical Standardization in the Pneumonia Etiology Research for Child Health Study

    J. Anthony G. Scott;J. Anthony G. Scott;Chizoba Wonodi;Jennifer C. Moïsi;Jennifer C. Moïsi;Maria Deloria-Knoll

  • Risk factors for severe respiratory syncytial virus infection among Alaska Native children

    Lisa R Bulkow;Rosalyn J Singleton;Rosalyn J Singleton;Ruth A Karron;Lee H Harrison

  • Differential Production of Inflammatory Cytokines in Primary Infection with Human Metapneumovirus and with Other Common Respiratory Viruses of Infancy

    Federico R. Laham;Victor Israele;Javier M. Casellas;Alejandro M. Garcia

  • Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP) — United States, 2014–15 Influenza Season

    Unknown

  • A Live Attenuated Bovine Parainfluenza Virus Type 3 Vaccine Is Safe, Infectious, Immunogenic, and Phenotypically Stable in Infants and Children

    Ruth A. Karron;Peter F. Wright;Peter F. Wright;Peter F. Wright;Susan L. Hall;Susan L. Hall;Susan L. Hall;Mamodikoe Makhene;Mamodikoe Makhene;Mamodikoe Makhene

  • The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.

    Peter F. Wright;Ruth A. Karron;Robert B. Belshe;Jian R. Shi

  • Mortality due to respiratory syncytial virus burden and risk factors

    Sarah Geoghegan;Anabella Erviti;Mauricio T Caballero;Fernando Vallone

  • Live-Attenuated Respiratory Syncytial Virus Vaccines

    Ruth A. Karron;Ursula J. Buchholz;Peter L. Collins

  • Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.

    Katherine L O'Brien;Aruna Chandran;Robert Weatherholtz;Hasan S Jafri

  • rDEN4Δ30, a Live Attenuated Dengue Virus Type 4 Vaccine Candidate, Is Safe, Immunogenic, and Highly Infectious in Healthy Adult Volunteers

    Anna P. Durbin;Stephen S. Whitehead;Julie McArthur;John R. Perreault

Frequent Co-Authors

David R. Murdoch
David R. Murdoch University of Otago
Shabir A. Madhi
Shabir A. Madhi University of the Witwatersrand
Martin Antonio
Martin Antonio London School of Hygiene & Tropical Medicine
Brian R. Murphy
Brian R. Murphy National Institute of Allergy and Infectious Diseases
Katherine L. O’Brien
Katherine L. O’Brien Johns Hopkins University
Peter L. Collins
Peter L. Collins National Institutes of Health
Daniel R. Feikin
Daniel R. Feikin Centers for Disease Control and Prevention
Maria Deloria Knoll
Maria Deloria Knoll Johns Hopkins University
Karen L. Kotloff
Karen L. Kotloff University of Maryland, Baltimore
Ursula J. Buchholz
Ursula J. Buchholz National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers that often require additional qualifications. For those looking to transition within nursing careers, programs such as the fnp to acute care np bridge program provide streamlined pathways to specialize further in patient care, particularly in acute settings.

Accelerated programs are another popular choice for advancing nursing careers efficiently. Many students pursue accelerated rn to np programs that allow registered nurses to become nurse practitioners faster, enhancing their scope of practice and career prospects.

For those entering nursing without prior clinical experience, accessible options like online rn programs for non nurses in florida offer flexible routes to achieve licensure and begin clinical work. Such programs are designed to accommodate diverse educational backgrounds.

Additionally, the easiest absn program to get into can be a practical starting point for students seeking a faster, less competitive entry into nursing, which complements immunology studies for clinical or research-focused careers.

Best Scientists Citing Ruth A. Karron

Trending Scientists

Recently Published Articles